<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03878082</url>
  </required_header>
  <id_info>
    <org_study_id>19MMHIS044e</org_study_id>
    <nct_id>NCT03878082</nct_id>
  </id_info>
  <brief_title>Propacetamol to Reduce Post Cesarean Section Uterine Contraction Pain</brief_title>
  <official_title>Perioperative Regular Usage of Propacetamol to Reduce Post Cesarean Section Uterine Contraction Pain and Opioid Consumption</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mackay Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mackay Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate that perioperative regular usage of propacetamol to reduce post cesarean section&#xD;
      uterine contraction pain and opioid consumption&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The most common method of pain control after cesarean section is intravenous patient-control&#xD;
      analgesia (IVPCA) with morphine. Multimodal analgesia could improve the quality of&#xD;
      perioperative pain control and reduceside effects of opioids. Previous researches marked that&#xD;
      perioperative pain after cesarean section includes somatic wound pain and visceral uterine&#xD;
      contraction pain.&#xD;
&#xD;
      According to Academy of Breastfeeding Medicine, propacetamol is a safe pain-killer for an&#xD;
      expectant mother and almost free from breast milk after intravenous injection. This study is&#xD;
      a prospective double-blind randomized-controlled trial to evaluate that propacetamol could&#xD;
      reduce visceral uterine contraction pain after cesarean section. Post cesarean section women&#xD;
      will divide into three groups:&#xD;
&#xD;
        1. pain control with IVPCA for 2 days&#xD;
&#xD;
        2. pain control with IVPCA and propacetamol 1g every 6 hours for 2 days&#xD;
&#xD;
        3. pain control with IVPCA and propacetamol 2g every 6 hours for 2 days&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 12, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of pain assessed by NRS</measure>
    <time_frame>Every 8 hours from post-anesthesia care unit to 2 days after the cesarean section</time_frame>
    <description>Change of pain assessed by Numerical Rating Scale: respondent selects a whole number (0-10 integers) that best reflects the intensity of the pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of treatment-relate adverse events</measure>
    <time_frame>Two days after the cesarean section</time_frame>
    <description>the complications or side effects during intervention, such as nausea/vomiting, skin itching, GI discomfort, urinary retention, and respiratory depression</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>Two days after the cesarean section</time_frame>
    <description>Comparison with the placebo group, the requirement of opoid</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfaction assessed by the NRS</measure>
    <time_frame>Two days after the cesarean section</time_frame>
    <description>Participants' satisfaction about post-operative pain management assessed by Numerical Rating Scale: respondent selects a whole number (0-10 integers , dissatisfied -&gt; satisfied) that best reflects the satisfaction.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Uterine Pain</condition>
  <arm_group>
    <arm_group_label>propacetamol 1g</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>pain control with IVPCA and propacetamol 1g every 6 hours for 2 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>propacetamol 2g</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>pain control with IVPCA and propacetamol 2g every 6 hours for 2 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IVPCA</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>pain control with IVPCA</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propacetamol 1g</intervention_name>
    <description>pain control with IVPCA and propacetamol 1g every 6 hours for 2 days</description>
    <arm_group_label>propacetamol 1g</arm_group_label>
    <other_name>Propacetamol 1g + IVPCA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propacetamol 2g</intervention_name>
    <description>pain control with IVPCA and propacetamol 2g every 6 hours for 2 days</description>
    <arm_group_label>propacetamol 2g</arm_group_label>
    <other_name>Propacetamol 2g + IVPCA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IVPCA</intervention_name>
    <description>pain control with IVPCA</description>
    <arm_group_label>IVPCA</arm_group_label>
    <arm_group_label>propacetamol 1g</arm_group_label>
    <arm_group_label>propacetamol 2g</arm_group_label>
    <other_name>IVPCA alone</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pregnancy more than 36 weeks which is expected to receive Caesarean section&#xD;
&#xD;
          -  Post Caesarean section woman, age greater than or equal to 20 years old&#xD;
&#xD;
          -  ASA physical status class 1 or 2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ASA physical status class 3 or above&#xD;
&#xD;
          -  Less than 20 years old&#xD;
&#xD;
          -  Past caesarean section for longitudinal wounds&#xD;
&#xD;
          -  Undergone major abdominal surgery&#xD;
&#xD;
          -  Chronic pain&#xD;
&#xD;
          -  Allergic to morphine or Propacetamol&#xD;
&#xD;
          -  Liver dysfunction&#xD;
&#xD;
          -  Treatment with anticoagulant&#xD;
&#xD;
          -  Emergency operation&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Post Caesarean section woman</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chien-Chung Huang, MD</last_name>
    <role>Study Director</role>
    <affiliation>Mackay Memorial Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chien-Chung Huang, MD</last_name>
    <phone>+886225433535</phone>
    <phone_ext>3009</phone_ext>
    <email>cchuang@dr.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>MacKay Memorial Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>104</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chien-Chung Huang, MD</last_name>
      <phone>+886225433535</phone>
      <phone_ext>3009</phone_ext>
      <email>cchuang@dr.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Valentine AR, Carvalho B, Lazo TA, Riley ET. Scheduled acetaminophen with as-needed opioids compared to as-needed acetaminophen plus opioids for post-cesarean pain management. Int J Obstet Anesth. 2015 Aug;24(3):210-6. doi: 10.1016/j.ijoa.2015.03.006. Epub 2015 Mar 23.</citation>
    <PMID>25936786</PMID>
  </reference>
  <reference>
    <citation>Ortiz MI, Ponce-Monter HA, Mora-Rodríguez JA, Barragán-Ramírez G, Barrón-Guerrero BS. Synergistic relaxing effect of the paracetamol and pyrilamine combination in isolated human myometrium. Eur J Obstet Gynecol Reprod Biol. 2011 Jul;157(1):22-6. doi: 10.1016/j.ejogrb.2011.02.011. Epub 2011 Mar 24.</citation>
    <PMID>21439705</PMID>
  </reference>
  <reference>
    <citation>Gadsden J, Hart S, Santos AC. Post-cesarean delivery analgesia. Anesth Analg. 2005 Nov;101(5 Suppl):S62-S69. doi: 10.1213/01.ANE.0000177100.08599.C8. Review.</citation>
    <PMID>16334493</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 7, 2019</study_first_submitted>
  <study_first_submitted_qc>March 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2019</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mackay Memorial Hospital</investigator_affiliation>
    <investigator_full_name>Chien-Chung,Huang</investigator_full_name>
    <investigator_title>attending physician, department of anesthesiology</investigator_title>
  </responsible_party>
  <keyword>cesarean section</keyword>
  <keyword>uterine contraction pain</keyword>
  <keyword>propacetamol</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Propacetamol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

